Valuation Sensorion

Stocks

Real-time Euronext Paris 03:05:33 2026-08-28 EDT			5-day change	1st Jan Change
0.2750 ^EUR	+0.36%		0.00%	-18.40%

06-11	Sensorion continues its decline despite Stifel's positive outlook
06-10	Sensorion Achieves Key Regulatory Milestones for Sens-601 for Gjb2-Related Hearing Loss and Selects Program as Lead Gene Therapy Candidate	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	153.4	29.56	80.38	191	101.3	141	-
Change	-	-80.74%	171.97%	137.65%	-47%	39.29%	-
Enterprise Value (EV) ¹	107.4	7.116	80.38	126.4	55.03	9.033	141
Change	-	-93.38%	1,029.56%	57.22%	-56.45%	-83.59%	1,461.28%
P/E	-10.1x	-1.28x	-2.53x	-7.07x	-3.37x	-36.5x	-6.09x
PBR	-	-	-	-	-	-	-
PEG	-	-0x	0.1x	0.2x	-0.3x	0.4x	-0x
Capitalization / Revenue	35.3x	5.9x	14.1x	28.7x	17.4x	6.45x	22.1x
EV / Revenue	24.7x	1.42x	14.1x	19x	9.47x	0.41x	22.1x
EV / EBITDA	-7.31x	-0.32x	-3.65x	-4.64x	-1.88x	0.13x	-
EV / EBIT	-7.15x	-0.31x	-3.6x	-4.45x	-1.79x	0.49x	-
EV / FCF	-9.56x	-0.31x	-	-5.74x	-2x	0.15x	-
FCF Yield	-10.5%	-321%	-	-17.4%	-50%	679%	-
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-0.19	-0.29	-0.17	-0.09	-0.1	-0.0075	-0.045
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	4.349	5.006	5.698	6.653	5.814	21.86	6.395
EBITDA ¹	-14.69	-22.37	-22.04	-27.24	-29.31	69.3	-
EBIT ¹	-15.02	-23.14	-22.31	-28.4	-30.75	18.45	-
Net income ¹	-15.14	-23.21	-22.06	-25.97	-29.43	-0.2367	-36.12
Net Debt ¹	-46.02	-22.44	-	-64.66	-46.22	-132	-
Reference price ²	1.9260	0.3700	0.4300	0.6360	0.3370	0.2740	0.2740
Nbr of stocks (in thousands)	79,672	79,881	186,936	300,362	300,458	514,720	-
Announcement Date	4/28/22	3/16/23	2/29/24	3/14/25	3/17/26	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SENSORION	-36.53x	0.41x	0.13x	-	164M
LONZA GROUP AG	34.55x	6.16x	18.31x	0.93%	51.14B
REVOLUTION MEDICINES, INC.	-22.47x	290.65x	-23.9x	-.--%	47.4B
IQVIA HOLDINGS INC.	33.79x	3.27x	14.13x	-.--%	43.19B
BEONE MEDICINES AG	48.79x	5.67x	30.99x	-.--%	42.35B
CELLTRION, INC.	29.05x	8.78x	22.18x	0.4%	33.23B
MEDPACE HOLDINGS, INC.	34.78x	5.7x	25.92x	-.--%	17.07B
EUROFINS SCIENTIFIC SE	24.34x	2.11x	9.14x	1.11%	14.76B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	79.29x	4.16x	16.13x	-.--%	14.15B
Average	25.07x	36.32x	12.56x	0.3%	29.27B
Weighted average by Cap.	27.56x	56.76x	12.41x	0.29%